Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (3,678,082)	$ (3,410,899)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	16,475	17,547
Stock option compensation expense	61,186	57,291
Share-based compensation - common stock	2,125	4,038
Common stock and warrants to consultants	213,800	85,200
Bad debt expense	$ 41	216,505
Unrealized gain on derivative instrument		(14,231)
Debt discount amortization	$ 402,918	217,323
Noncash finance charges		17,591
Loss on conversion of notes	$ 2,588	63,867
Loss on settlement of note and warrant		132,301
Changes in assets and liabilities:
Receivables	$ (30,803)	(75,494)
Prepaid expenses and other current assets	195,068	(187,935)
Inventory	90,000	160,000
Accounts payable, accrued expenses and other liabilities	1,207,086	1,641,927
Deferred revenue	(13,286)	13,286
Net cash used in operating activities	(1,530,883)	(1,061,683)
Cash flows from investing activities:
Purchases of property and equipment	(4,561)	(45,581)
Net cash used in investing activities	(4,561)	(45,581)
Cash flows from financing activities:
Proceeds from notes payable	1,257,000	467,500
Repayment of note and warrant settlement	(42,500)	(242,000)
Proceeds from common stock and warrants	365,000	830,500
Net cash provided by financing activities	1,579,500	1,056,000
Net increase (decrease) in cash	44,056	(51,264)
Cash at beginning of year	5,745	57,009
Cash at end of year	49,801	$ 5,745
Supplemental Cash Flow Information
Cash Paid for interest	$ 10,000